Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Positron-Emission Tomography and Assessment of Cancer Therapy | New England Journal of
Medicine Skip to main content Access provided byTE WHATU ORA HEALTH NEW ZEALAND …

Purpose To develop guidelines for performing and interpreting positron emission
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …

Currently availabel staging systems for non-Hodgkin lymphomas are not useful for clinical
staging classification of most primary cutaneous lymphomas. The tumor, node, metastases …

Abstract Background and Objectives Bone lesions in multiple myeloma (MM) have been
traditionally detected by whole body X-ray (WBXR) survey although magnetic resonance …

The disease we now call diffuse large B-cell lymphoma has gone by many names in the
past. These have included reticulum cell sarcoma, 1 diffuse histiocytic lymphoma, 2 and …

BACKGROUND Fluorine‐18 fluoro‐deoxyglucose positron emission tomography (FDG‐
PET) scanning has excellent sensitivity and specificity for staging non‐Hodgkin lymphomas …

BACKGROUND. Although studies comparing conventional imaging modalities with 18F‐
fluorodeoxyglucose positron emission tomography (18F‐FDG‐PET) for the detection of …

The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …

OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming
familiar with the role of PET/CT in baseline staging and therapeutic response assessment in …